Global Orally Disintegrating Tablet Sales Market Report 2018

Publisher Name :
Date: 26-Feb-2018
No. of pages: 168
Inquire Before Buying

This report studies the Orally Disintegrating Tablet market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Orally Disintegrating Tablet market by product type and applications/end industries.

In the last several years, global market of Orally Disintegrating Tablet developed rapidly, with an average growth rate of 13%, In 2017, global revenue of Orally Disintegrating Tablet is nearly 11200 M USD; the actual production is about 2100 million units.

The major players in global Orally Disintegrating Tablet market include

Teva

Merck

Mylan

Pfizer

Johnson and Johnson

GSK

Otsuka

Eli Lilly and Company

AstraZeneca

Bristol-Myers Squibb

Conquer

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Orally Disintegrating Tablet in these regions, from 2013 to 2025 (forecast), covering

North America

Europe

China

Japan

India

South America

Other

On the basis of product, the Orally Disintegrating Tablet market is primarily split into

Anti-Psychotics Drug

Anti-Epileptics Drug

Other

On the basis on the end users/applications, this report covers

CNS Diseases

Gastrointestinal Diseases

CVS Diseases

Other

Global Orally Disintegrating Tablet Sales Market Report 2018

Table of Contents
1 Orally Disintegrating Tablet Market Overview 1
1.1 Product Overview and Scope of Orally Disintegrating Tablet 1
1.2 Classification of Orally Disintegrating Tablet by Product Category 2
1.2.1 Global Orally Disintegrating Tablet Sales Comparison by Types (2013-2025) 2
1.2.2 Global Orally Disintegrating Tablet Sales Market Share by Types in 2017 2
1.2.3 Anti-Psychotics Drug 3
1.2.4 Anti-Epileptics Drug 3
1.3 Global Orally Disintegrating Tablet Market by Applications/End Users 4
1.3.1 Global Orally Disintegrating Tablet Sales Comparison by Applications (2013-2025) 4
1.3.2 CNS Diseases 5
1.3.3 Gastrointestinal Diseases 5
1.4 Global Orally Disintegrating Tablet Market by Regions 5
1.4.1 Global Orally Disintegrating Tablet Revenue Comparison by Regions (2013-2025) 5
1.4.2 North America Orally Disintegrating Tablet Status and Prospect (2013-2025) 6
1.4.3 Europe Orally Disintegrating Tablet Status and Prospect (2013-2025) 7
1.4.4 China Orally Disintegrating Tablet Status and Prospect (2013-2025) 8
1.4.5 Japan Orally Disintegrating Tablet Status and Prospect (2013-2025) 9
1.4.6 India Orally Disintegrating Tablet Status and Prospect (2013-2025) 10
1.4.7 South America Orally Disintegrating Tablet Status and Prospect (2013-2025) 11
1.5 Global Orally Disintegrating Tablet Sales and Revenue (2013-2025) 12
1.5.1 Global Orally Disintegrating Tablet Sales and Growth Rate (2013-2025) 12
1.5.2 Global Orally Disintegrating Tablet Revenue and Growth Rate (2013-2025) 13
2 Global Orally Disintegrating Tablet Competition by Players, Type and Application 14
2.1 Global Orally Disintegrating Tablet Market Competition by Players 14
2.1.1 Global Orally Disintegrating Tablet Sales and Market Share of Key Players (2017-2018) 14
2.1.2 Global Orally Disintegrating Tablet Revenue and Share by Players (2017-2018) 16
2.2 Global Orally Disintegrating Tablet Sales and Revenue by Type 19
2.2.1 Global Orally Disintegrating Tablet Sales and Market Share by Type (2013-2018) 19
2.2.2 Global Orally Disintegrating Tablet Revenue and Market Share by Type (2013-2018) 21
2.3 Global Orally Disintegrating Tablet Sales and Revenue by Regions 23
2.3.1 Global Orally Disintegrating Tablet Sales and Market Share by Regions (2013-2018) 23
2.3.2 Global Orally Disintegrating Tablet Revenue and Market Share by Regions (2013-2018) 25
2.4 Global Orally Disintegrating Tablet Sales by Application 27
3 North America Orally Disintegrating Tablet (Sales, Revenue and Price) 29
3.1 North America Orally Disintegrating Tablet Sales and Revenue (2013-2018) 29
3.1.1 North America Orally Disintegrating Tablet Sales and Growth Rate (2013-2018) 29
3.1.2 North America Orally Disintegrating Tablet Revenue and Growth Rate (2013-2018) 30
3.1.3 North America Orally Disintegrating Tablet Price Trend (2013-2018) 31
3.2 North America Orally Disintegrating Tablet Sales and Market Share by Players 31
3.3 North America Orally Disintegrating Tablet Sales and Market Share by Type 33
3.4 North America Orally Disintegrating Tablet Sales and Market Share by Application 34
4 China Orally Disintegrating Tablet (Sales, Revenue and Price) 36
4.1 China Orally Disintegrating Tablet Sales and Revenue (2013-2018) 36
4.1.1 China Orally Disintegrating Tablet Sales and Growth Rate (2013-2018) 36
4.1.2 China Orally Disintegrating Tablet Revenue and Growth Rate (2013-2018) 37
4.1.3 China Orally Disintegrating Tablet Price Trend (2013-2018) 38
4.2 China Orally Disintegrating Tablet Sales and Market Share by Players 38
4.3 China Orally Disintegrating Tablet Sales and Market Share by Type 40
4.4 China Orally Disintegrating Tablet Sales and Market Share by Application 41
5 Europe Orally Disintegrating Tablet (Sales, Revenue and Price) 43
5.1 Europe Orally Disintegrating Tablet Sales and Value (2013-2018) 43
5.1.1 Europe Orally Disintegrating Tablet Sales and Growth Rate (2013-2018) 43
5.1.2 Europe Orally Disintegrating Tablet Revenue and Growth Rate (2013-2018) 44
5.1.3 Europe Orally Disintegrating Tablet Price Trend (2013-2018) 45
5.2 Europe Orally Disintegrating Tablet Sales and Market Share by Players 45
5.3 Europe Orally Disintegrating Tablet Sales and Market Share by Type 47
5.4 Europe Orally Disintegrating Tablet Sales and Market Share by Application 48
6 Japan Orally Disintegrating Tablet (Sales, Revenue and Price) 50
6.1 Japan Orally Disintegrating Tablet Sales and Value (2013-2018) 50
6.1.1 Japan Orally Disintegrating Tablet Sales and Growth Rate (2013-2018) 50
6.1.2 Japan Orally Disintegrating Tablet Revenue and Growth Rate (2013-2018) 51
6.1.3 Japan Orally Disintegrating Tablet Price Trend (2013-2018) 52
6.2 Japan Orally Disintegrating Tablet Sales and Market Share by Players 52
6.3 Japan Orally Disintegrating Tablet Sales and Market Share by Type 54
6.4 Japan Orally Disintegrating Tablet Sales and Market Share by Application 55
7 India Orally Disintegrating Tablet (Sales, Revenue and Price) 57
7.1 India Orally Disintegrating Tablet Sales and Value (2013-2018) 57
7.1.1 India Orally Disintegrating Tablet Sales and Growth Rate (2013-2018) 57
7.1.2 India Orally Disintegrating Tablet Revenue and Growth Rate 58
7.1.3 India Orally Disintegrating Tablet Price Trend 59
7.2 India Orally Disintegrating Tablet Sales and Market Share by Players 59
7.3 India Orally Disintegrating Tablet Sales and Market Share by Type 61
7.4 India Orally Disintegrating Tablet Sales and Market Share by Application 62
8 South America Orally Disintegrating Tablet (Sales, Revenue and Price) 64
8.1 South America Orally Disintegrating Tablet Sales and Value (2013-2018) 64
8.1.1 South America Orally Disintegrating Tablet Sales and Growth Rate (2013-2018) 64
8.1.2 South America Orally Disintegrating Tablet Revenue and Growth Rate (2013-2018) 65
8.1.3 South America Orally Disintegrating Tablet Price Trend 66
8.2 South America Orally Disintegrating Tablet Sales and Market Share by Players 66
8.3 South America Orally Disintegrating Tablet Sales and Market Share by Type 68
8.4 South America Orally Disintegrating Tablet Sales and Market Share by Application 69
9 Analysis of Orally Disintegrating Tablet Industry Key Manufacturers 71
9.1 Teva 71
9.1.1 Company Profile 71
9.1.2 Product Information 72
9.1.3 Sales, Price, Cost, Gross, and Revenue 72
9.2 Merck 73
9.2.1 Company Profile 73
9.2.2 Product Information 74
9.2.3 Sales, Price, Cost, Gross, and Revenue 74
9.3 Mylan 75
9.3.1 Company Profile 75
9.3.2 Product Information 76
9.3.3 Sales, Price, Cost, Gross, and Revenue 76
9.4 Pfizer 77
9.4.1 Company Profile 77
9.4.2 Product Information 78
9.4.3 Sales, Price, Cost, Gross, and Revenue 78
9.5 Johnson and Johnson 79
9.5.1 Company Profile 79
9.5.2 Product Information 80
9.5.3 Sales, Price, Cost, Gross, and Revenue 80
9.6 GSK 81
9.6.1 Company Profile 81
9.6.2 Product Information 82
9.6.3 Sales, Price, Cost, Gross, and Revenue 82
9.7 Otsuka 83
9.7.1 Company Profile 83
9.7.2 Product Information 84
9.7.3 Sales, Price, Cost, Gross, and Revenue 84
9.8 Eli Lilly and Company 84
9.8.1 Company Profile 84
9.8.2 Product Information 86
9.8.3 Sales, Price, Cost, Gross, and Revenue 86
9.9 AstraZeneca 87
9.9.1 Company Profile 87
9.9.2 Product Information 88
9.9.3 Sales, Price, Cost, Gross, and Revenue 88
9.10 Bristol-Myers Squibb 89
9.10.1 Company Profile 89
9.10.2 Product Information 90
9.10.3 Sales, Price, Cost, Gross, and Revenue 90
9.11 Conquer 91
9.11.1 Company Profile 91
9.11.2 Product Information 92
9.11.3 Sales, Price, Cost, Gross, and Revenue 92
10 Orally Disintegrating Tablet Manufacturing Cost Analysis 93
10.1 Orally Disintegrating Tablet R&D Cost Analysis 93
10.1.1 Clinical Phase Costs 94
10.1.2 Capitalized Costs 95
10.2 Proportion of Manufacturing Cost Structure 96
10.2.1 Raw Materials 96
10.2.2 Labor Cost 98
10.2.3 Other Costs Analysis 102
10.3 Manufacturing Process Analysis of Orally Disintegrating Tablet 108
11 Industrial Chain, Sourcing Strategy and Downstream Buyers 109
11.1 Orally Disintegrating Tablet Industrial Chain Analysis 109
11.2 Upstream Raw Materials Sourcing 110
11.3 Downstream Buyers 110
12 Marketing Strategy Analysis, Distributors/Traders 113
12.1 Marketing Channel 113
12.1.1 Direct Marketing 113
12.1.2 Indirect Marketing 114
12.1.3 Marketing Channel Development Trend 115
12.2 Market Positioning 115
12.2.1 Pricing Strategy 115
12.2.2 Brand Strategy 117
12.3 Distributors/Traders List 118
13 Market Effect Factors Analysis 120
13.1 Technology Progress/Risk 120
13.2 Consumer Needs/Customer Preference Change 121
13.3 Economic/Political Environmental Change 122
14 Global Orally Disintegrating Tablet Market Forecast (2019-2025) 132
14.1 Global Orally Disintegrating Tablet Sales, Revenue and Price Forecast (2019-2025) 132
14.1.1 Global Orally Disintegrating Tablet Sales and Growth Rate Forecast (2019-2025) 132
14.1.2 Global Orally Disintegrating Tablet Revenue and Growth Rate Forecast (2019-2025) 133
14.1.3 Global Orally Disintegrating Tablet Price and Trend Forecast (2019-2025) 134
14.2 Global Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast by Regions (2019-2025) 134
14.2.1 Global Orally Disintegrating Tablet Sales and Growth Rate Forecast by Regions (2019-2025) 134
14.2.2 Global Orally Disintegrating Tablet Revenue and Growth Rate Forecast by Regions (2019-2025) 136
14.2.3 North America Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast (2019-2025) 138
14.2.4 Europe Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast (2019-2025) 139
14.2.5 China Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast (2019-2025) 140
14.2.6 Japan Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast (2019-2025) 141
14.2.7 India Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast (2019-2025) 142
14.2.8 South America Orally Disintegrating Tablet Sales, Revenue and Growth Rate Forecast (2019-2025) 143
14.3 Global Orally Disintegrating Tablet Sales Forecast by Type (2019-2025) 144
14.4 Global Orally Disintegrating Tablet Sales Forecast by Application (2019-2025) 145
15 Research Findings and Conclusion 146
16 Methodology and Data Source 147
16.1 Methodology/Research Approach 147
16.1.1 Research Programs/Design 147
16.1.2 Market Size Estimation 148
16.1.3 Market Breakdown and Data Triangulation 149
16.2 Data Source 150
16.2.1 Secondary Sources 150
16.2.2 Primary Sources 151
16.3 Disclaimer 152
16.4 Author List 153
List of Tables and Figures
Figure Product Picture of Orally Disintegrating Tablet 1
Table Global Orally Disintegrating Tablet Sales (M Units) Comparison by Types (2013-2025) 2
Figure Global Orally Disintegrating Tablet Sales Market Share by Types in 2017 2
Figure Anti-Psychotics Drug Product Picture 3
Figure Anti-Epileptics Drug Product Picture 3
Table Global Orally Disintegrating Tablet Sales (M Units) Comparison by Applications (2013-2025) 4
Figure Global Sales Market Share of Orally Disintegrating Tablet by Applications in 2017 4
Figure CNS Diseases Examples 5
Figure Gastrointestinal Diseases Examples 5
Table Global Market Orally Disintegrating Tablet Revenue (M USD) Comparison by Regions 2013-2025 5
Figure North America Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 6
Figure Europe Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 7
Figure China Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 8
Figure Japan Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 9
Figure India Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 10
Figure South America Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 11
Figure Global Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2025) 12
Figure Global Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2025) 13
Table Global Orally Disintegrating Tablet Sales (M Units) of Key Players (2017-2018) 14
Table Global Orally Disintegrating Tablet Sales Share (%) by Players (2017-2018) 14
Figure 2017 Global Orally Disintegrating Tablet Sales Share (%) by Players 15
Figure 2018 Global Orally Disintegrating Tablet Sales Share (%) by Players 16
Table Global Orally Disintegrating Tablet Revenue (M USD) by Players (2017-2018) 16
Table Global Orally Disintegrating Tablet Revenue Share (%) by Players (2017-2018) 17
Figure 2017 Global Orally Disintegrating Tablet Revenue Share (%) by Players 18
Figure 2018 Global Orally Disintegrating Tablet Revenue Share (%) by Players 19
Table Global Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 19
Table Global Orally Disintegrating Tablet Sales Share (%) by Type (2013-2018) 20
Figure Sales Market Share (%) of Orally Disintegrating Tablet by Type (2013-2018) 20
Figure Global Orally Disintegrating Tablet Sales Growth Rate by Type (2013-2018) 21
Table Global Orally Disintegrating Tablet Revenue (M USD) by Type (2013-2018) 21
Table Global Orally Disintegrating Tablet Revenue Share (%) by Type (2013-2018) 21
Figure Revenue Market Share (%) of Orally Disintegrating Tablet by Type (2013-2018) 22
Figure Global Orally Disintegrating Tablet Revenue Growth Rate by Type (2013-2018) 22
Table Global Orally Disintegrating Tablet Sales (M Units) by Regions (2013-2018) 23
Table Global Orally Disintegrating Tablet Sales Share (%) by Regions (2013-2018) 23
Figure Sales Market Share (%) of Orally Disintegrating Tablet by Regions (2013-2018) 24
Figure Global Orally Disintegrating Tablet Sales Market Share (%) by Regions in 2017 24
Table Global Orally Disintegrating Tablet Revenue (M USD) by Regions (2013-2018) 25
Table Global Orally Disintegrating Tablet Revenue Share (%) by Regions (2013-2018) 25
Figure Revenue Market Share (%) of Orally Disintegrating Tablet by Regions (2013-2018) 26
Figure Global Orally Disintegrating Tablet Revenue Market Share (%) by Regions in 2017 26
Table Global Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 27
Table Global Orally Disintegrating Tablet Sales Share (%) by Application (2013-2018) 27
Figure Sales Market Share (%) of Orally Disintegrating Tablet by Application (2013-2018) 28
Figure Global Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 28
Figure North America Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) (2013-2018) 29
Figure North America Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2018) 30
Figure North America Orally Disintegrating Tablet Price (USD/Unit) Trend (2013-2018) 31
Table North America Orally Disintegrating Tablet Sales (M Units) by Players (2017-2018) 31
Table North America Orally Disintegrating Tablet Sales (M Units) Market Share (%) by Players (2017-2018) 32
Figure North America Orally Disintegrating Tablet Sales (M Units) Market Share (%) by Players in 2017 33
Table North America Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 33
Table North America Orally Disintegrating Tablet Sales Market Share (%) by Type (2013-2018) 33
Figure North America Orally Disintegrating Tablet Sales Market Share (%) by Type in 2017 34
Table North America Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 34
Table North America Orally Disintegrating Tablet Sales Market Share (%) by Application (2013-2018) 35
Figure North America Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 35
Figure China Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2018) 36
Figure China Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2018) 37
Figure China Orally Disintegrating Tablet Price (USD/Unit) Trend (2013-2018) 38
Table China Orally Disintegrating Tablet Sales (M Units) by Players (2017-2018) 38
Table China Orally Disintegrating Tablet Sales Market Share (%) by Players (2017-2018) 39
Figure China Orally Disintegrating Tablet Sales Market Share (%) by Players in 2017 40
Table China Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 40
Table China Orally Disintegrating Tablet Sales Market Share (%) by Type (2013-2018) 40
Figure China Orally Disintegrating Tablet Sales (M Units) Market Share (%) by Type in 2017 41
Table China Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 41
Table China Orally Disintegrating Tablet Sales Market Share (%) by Application (2013-2018) 42
Figure China Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 42
Figure Europe Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2018) 43
Figure Europe Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2018) 44
Figure Europe Orally Disintegrating Tablet Price (USD/Unit) Trend (2013-2018) 45
Table Europe Orally Disintegrating Tablet Sales (M Units) by Players (2017-2018) 45
Table Europe Orally Disintegrating Tablet Sales Market Share (%) by Players (2017-2018) 46
Figure Europe Orally Disintegrating Tablet Sales Market Share (%) by Players in 2017 47
Table Europe Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 47
Table Europe Orally Disintegrating Tablet Sales Market Share (%) by Type (2013-2018) 47
Figure Europe Orally Disintegrating Tablet Sales Market Share (%) by Type in 2017 48
Table Europe Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 48
Table Europe Orally Disintegrating Tablet Sales Market Share (%) by Application (2013-2018) 49
Figure Europe Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 49
Figure Japan Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2018) 50
Figure Japan Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2018) 51
Figure Japan Orally Disintegrating Tablet Price (USD/Unit) Trend (2013-2018) 52
Table Japan Orally Disintegrating Tablet Sales (M Units) by Players (2017-2018) 52
Table Japan Orally Disintegrating Tablet Sales Market Share (%) by Players (2017-2018) 53
Figure Japan Orally Disintegrating Tablet Sales Market Share (%) by Players in 2017 53
Table Japan Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 54
Table Japan Orally Disintegrating Tablet Sales Market Share (%) by Type (2013-2018) 54
Figure Japan Orally Disintegrating Tablet Sales Market Share (%) by Type in 2017 54
Table Japan Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 55
Table Japan Orally Disintegrating Tablet Sales Market Share (%) by Application (2013-2018) 55
Figure Japan Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 56
Figure India Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2018) 57
Figure India Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2018) 58
Figure India Orally Disintegrating Tablet Price (USD/Unit) Trend (2013-2018) 59
Table India Orally Disintegrating Tablet Sales (M Units) by Players (2017-2018) 59
Table India Orally Disintegrating Tablet Sales Market Share (%) by Players (2017-2018) 60
Figure India Orally Disintegrating Tablet Sales Market Share (%) by Players in 2017 60
Table India Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 61
Table India Orally Disintegrating Tablet Sales Market Share (%) by Type (2013-2018) 61
Figure India Orally Disintegrating Tablet Sales Market Share (%) by Type in 2017 61
Table India Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 62
Table India Orally Disintegrating Tablet Sales Market Share (%) by Application (2013-2018) 62
Figure India Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 63
Figure South America Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2018) 64
Figure South America Orally Disintegrating Tablet Revenue (M USD) and Growth Rate (2013-2018) 65
Figure South America Orally Disintegrating Tablet Price (USD/Unit) Trend (2013-2018) 66
Table South America Orally Disintegrating Tablet Sales (M Units) by Players (2017-2018) 66
Table South America Orally Disintegrating Tablet Sales Market Share (%) by Players (2017-2018) 67
Figure South America Orally Disintegrating Tablet Sales Market Share (%) by Players in 2017 67
Table South America Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018) 68
Table South America Orally Disintegrating Tablet Sales Market Share (%) by Type (2013-2018) 68
Figure South America Orally Disintegrating Tablet Sales Market Share (%) by Type in 2017 69
Table South America Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018) 69
Table South America Orally Disintegrating Tablet Sales Market Share (%) by Application (2013-2018) 69
Figure South America Orally Disintegrating Tablet Sales Market Share (%) by Application in 2017 70
Table Teva Company Profile 71
Figure Orally Disintegrating Tablet Product Picture of Teva 72
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2017-2018 72
Table Merck Company Profile 73
Figure Orally Disintegrating Tablet Product Picture of Merck 74
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2017-2018 74
Table Mylan Company Profile 75
Figure Orally Disintegrating Tablet Product Picture of Mylan 76
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2017-2018 76
Table Pfizer Company Profile 77
Figure Orally Disintegrating Tablet Product Picture of Pfizer 78
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2018 78
Table Johnson and Johnson Company Profile 79
Figure Orally Disintegrating Tablet Product Picture of Johnson and Johnson 80
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson and Johnson 2017-2018 80
Table GSK Company Profile 81
Figure Orally Disintegrating Tablet Product Picture of GSK 82
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of GSK 2017-2018 82
Table Otsuka Company Profile 83
Figure Orally Disintegrating Tablet Product Picture of Otsuka 84
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Otsuka 2017-2018 84
Table Eli Lilly and Company Company Profile 84
Figure Orally Disintegrating Tablet Product Picture of Eli Lilly and Company 86
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly and Company 2017-2018 86
Table AstraZeneca Company Profile 87
Figure Orally Disintegrating Tablet Product Picture of AstraZeneca 88
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2017-2018 88
Table Bristol-Myers Squibb Company Profile 89
Figure Orally Disintegrating Tablet Product Picture of Bristol-Myers Squibb 90
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2017-2018 90
Table Conquer Company Profile 91
Figure Orally Disintegrating Tablet Product Picture of Conquer 92
Table Orally Disintegrating Tablet Sales (M Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Conquer 2017-2018 92
Figure typical phases from research to the market for a drug candidate 94
Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound 95
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 96
Figure Manufacturing Cost Structure of Orally Disintegrating Tablet 96
Figure Assessment of API Manufacturing Cost by Region 97
Figure USA Labor Cost Analysis 2012-2016 98
Figure Cost of Employing a Factory Worker 99
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe 100
Figure Monthly Minimum Wages in Asia 2016 101
Figure China Labor Costs 2013-2016 101
Table Average Price of Electricity to Ultimate Customers 2007-2016 102
Figure Electricity Prices for Household Consumers in 2016 104
Figure Summary of the Driving Assumptions 105
Figure Industrial Electric Rates 2016 (PER KWH) 106
Figure Manufacturing Process Analysis of Orally Disintegrating Tablet 108
Figure Orally Disintegrating Tablet Industrial Chain Analysis 109
Table Major Buyers of Orally Disintegrating Tablet 110
Figure Market Channel of Orally Disintegrating Tablet 115
Figure Setting Pricing Policy 116
Table Distributors/Traders List 118
Figure Synonyms of ODTs 120
Figure Ideal Properties of ODTs 120
Figure Advantages of ODTs 121
Table Advantages of ODTs 121
Figure Global GDP Growth Rate for 2016 122
Figure Real GDP Growth 2016-2020 annual Average 124
Figure US GDP 2006-2016 (Billion USD) 125
Figure US CPI Change 2016-2017 125
Figure EU GDP 2006-2016 (Billion USD) 126
Figure EU CPI Change 2012-2016 126
Figure Germany GDP 2006-2016 (Billion USD) 127
Figure Germany CPI Change 2016-2017 127
Figure UK GDP 2006-2016 (Billion USD) 127
Figure UK CPI Change 2016-2017 128
Figure Italy GDP 2006-2016 (Billion USD) 128
Figure Italy CPI Change 2016-2017 129
Figure Japan GDP 2006-2016 (Billion USD) 129
Figure Japan CPI Change 2012-2016 130
Figure China GDP 2006-2016 (Billion USD) 130
Figure China CPI Change 2016-2017 131
Figure Global Orally Disintegrating Tablet Sales (M Units) and Growth Rate Forecast (2019-2025) 132
Figure Global Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 133
Figure Global Orally Disintegrating Tablet Price (USD/Unit) and Trend Forecast (2019-2025) 134
Table Global Orally Disintegrating Tablet Sales (M Units) Forecast by Regions (2019-2025) 134
Figure Global Orally Disintegrating Tablet Sales Market Share (%) Forecast by Regions (2019-2025) 135
Figure Global Orally Disintegrating Tablet Sales Market Share (%) Forecast by Regions in 2025 136
Table Global Orally Disintegrating Tablet Revenue (M USD) Forecast by Regions (2019-2025) 136
Figure Global Orally Disintegrating Tablet Revenue Market Share (%) Forecast by Regions (2019-2025) 137
Figure Global Orally Disintegrating Tablet Revenue Market Share (%) Forecast by Regions in 2025 137
Figure North America Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) Forecast (2019-2025) 138
Figure North America Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 138
Figure Europe Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) Forecast (2019-2025) 139
Figure Europe Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 139
Figure China Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) Forecast (2019-2025) 140
Figure China Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 140
Figure Japan Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) Forecast (2019-2025) 141
Figure Japan Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 141
Figure India Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) Forecast (2019-2025) 142
Figure India Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 142
Figure South America Orally Disintegrating Tablet Sales (M Units) and Growth Rate (%) Forecast (2019-2025) 143
Figure South America Orally Disintegrating Tablet Revenue (M USD) and Growth Rate Forecast (2019-2025) 143
Table Global Orally Disintegrating Tablet Sales (M Units) Forecast by Type (2019-2025) 144
Figure Global Orally Disintegrating Tablet Sales Market Share (%) Forecast by Type (2019-2025) 144
Table Global Orally Disintegrating Tablet Sales (M Units) Forecast by Application (2019-2025) 145
Figure Global Orally Disintegrating Tablet Sales Market Share (%) Forecast by Application (2019-2025) 145
Table Research Programs/Design for This Report 147
Figure Bottom-up and Top-down Approaches for This Report 149
Figure Data Triangulation 150
Table Key Data Information from Secondary Sources 151
Table Key Data Information from Primary Sources 152
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Active Pharmaceutical Ingredients: Global Markets to 2022
    Published: 12-Jun-2018        Price: US 5500 Onwards        Pages: 164
    Report Scope This report (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines that impact the procurement of API are studied here. The increasing importance of API outsourced manufacturing activities and the impact on the pharmaceutical industry are co......
  • Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 3500 Onwards        Pages: 45
    Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Pipeline Review, H1 2018 Summary Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules ......
  • Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 3500 Onwards        Pages: 39
    Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H1 2018 Summary According to the recently published report 'Tryptophan 2,3 Dioxygenase - Pipeline Review, H1 2018'; Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) pipeline Target constitutes close to 12 molecules......
  • Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 3500 Onwards        Pages: 67
    Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H1 2018 Summary Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Proto-oncogene tyrosine-protein kinase ROS is an enzyme that in humans is encoded by the ROS1 gen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs